Article

Utility of Polymerase Chain Reaction for Analysis of Antigen Receptor Rearrangement in Staging and Predicting Prognosis in Dogs with Lymphoma

2006-03-01

Abstract excerpt

Abstract In lymphoid neoplasia, molecular assays to confirm clonality rely on the fact that lymphoid cells normally contain DNA regions with unique sequences, resulting from recombination of the V, D, and J genes. The purpose of this study was to determine the utility of polymerase chain reaction (PCR) for antigen receptor rearrangements (PARR) for molecular staging and predicting prognosis in canine lymphoma. We...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8ad622b9-7480-5f02-959c-9d3f6f362ab9
DOI: 10.1111/j.1939-1676.2006.tb02864.x

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Utility of Polymerase Chain Reaction for Analysis of Antigen Receptor Rearrangement in Staging and Predicting Prognosis in Dogs with LymphomaDOI 10.1111/j.1939-1676.2006.tb02864.xRead

Utility of Polymerase Chain Reaction for Analysis of Antigen Receptor Rearrangement in Staging and Predicting Prognosis in Dogs with LymphomaSemantic proximity Read

Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.Semantic proximity Read

Diagnosis of Canine Lymphoid Neoplasia Using Clonal Rearrangements of Antigen Receptor GenesSemantic proximity Read

Detection of clonal antigen receptor gene rearrangement in dogs with lymphoma by real-time polymerase chain reaction and melting curve analysisSemantic proximity Read

Development of the polymerase chain reaction assay based on the canine genome database for detection of monoclonality in B cell lymphomaSemantic proximity Read

Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood.Semantic proximity Read

Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reactionSemantic proximity Read

Interest of circulating tumor DNA as a biomarker for canine cancers: illustration in histiocytic sarcoma, oral malignant melanoma and multicentric lymphomaSemantic proximity Read

Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.Semantic proximity Read

Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.Semantic proximity Read

Assessment of immunoglobulin heavy chain, immunoglobulin light chain, and T‐cell receptor clonality testing in the diagnosis of feline lymphoid neoplasiaSemantic proximity Read

MicroRNA profiling in canine multicentric lymphomaSemantic proximity Read